Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 23 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
221 25.0 months Newly diagnosed GBM Radiation
University of Maryland School of Medicine United States 1/2002
Treatment Details: Patients: This study involved 64 patients with glioblastoma multiforme. Most patients had undergone previous surgery. Patients were divided into two groups: Group 1 contained 33 patients;
 
222 24.9 months metastatic breast cancer 4 Chemotherapy
University Hospital (Vienna) Austria 3/2005
Treatment Details: Patients: This Phase III study involved 259 women with metastatic breast cancer. The patients were randomly placed into two groups: Group B had 135 patients (median age age 54). Metastatic
 
223 24.9 months Liver 2 Chemotherapy
Immunotherapy
Surgery
Tianjin Medical University Cancer Institute & Hospital China 12/2013
Treatment Details: Patients: This phase 2 study involved 66 hepatocellular carcinoma patients who had not been previously treated. Twenty-nine of the patients were 60 years old or older and 58 were male.
 
224 24.8 months Advanced breast cancer 5 Biologic therapy
Chemotherapy
Karolinska Institutet and University Hospital Sweden 2/2012
Treatment Details: Patients: This phase III study involved women with advanced breast cancer who were separated into two separate treatment groups. Group A consisted of 296 patients with a median age of 54 y
 
225 24.8 months Advanced breast cancer 4 Chemotherapy
Regina Elena National Cancer Institute Italy 4/2011
Treatment Details: Patients: This study involved women with advanced breast cancer who had not received prior anthracycline-based therapy. Patients were divided into two separate treatment groups. Group A c
 
226 24.8 months Metastatic breast cancer 4 Chemotherapy
Hospital Clı´nico Universitario Virgen de la Victoria Spain 7/2010
Treatment Details: Patients: This study involved 78 women with newly diagnosed metastatic breast cancer who had received prior doxorubicin and docetaxel treatment. The median patient age was 58 years. Tre
 
227 24.7 months Metastatic breast cancer (select group) 3 Biologic therapy
Montefiore Medical Center United States 12/2004
Treatment Details: Patients: This Phase III trial involved 179 patients with metastatic breast cancer whose cancers did not grow or spread (progress) after being treated with chemotherapy. Treatment: Of
 
228 24.7 months Metastatic breast cancer 4 Biologic therapy
Chemotherapy
The West Clinic United States 6/2014
Treatment Details: Patients: This phase 2 study involved female metastatic breast cancer patients who were divided into two separate groups based on treatment and genetic status of their cancer. Group A cons
 
229 24.6 months Advanced Breast Cancer 5 Chemotherapy
PUCRS School of Medicine Brazil 3/2010
Treatment Details: Patients: This phase III trial involved women with HER2-negative advanced breast cancer that recurred following treatment with anthracycline and taxane. The study was divided into two grou
 
230 24.6 months Androgen-independent prostate cancer 4 Biologic therapy
Chemotherapy
Cedars-Sinai Medical Center United States 7/2007
Treatment Details: Patients: This phase II study involved 22 elderly patients with androgen-independent, progressive prostate cancer. The median age was 73.5 years, ranging from 65 to 80. Treatment: Th
 
Page 23 of 187  | Previous Page  | Next Page